Consolidated PD-L1 inhibitors after chemoradiotherapy versus placebo in non-resectable non–small cell lung carcinoma: A meta-analysis of phase III randomized controlled trials. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results